Aug. 8, 2019: Casual sex partners increase among U.S. MSM; why some MSM undervalue PrEP; proteinuria prevalence and fracture risk; cannabis, cocaine, and inflammation in people living with HIV.
April 18, 2019: lamivudine/raltegravir for PrEP; feminizing hormone may impact PrEP efficacy; why TAF has a better renal profile than TDF; the role of internet dating in HIV incidence trends.
The first case of Fanconi syndrome associated with PrEP was reported in a poster at the 18th International Workshop on Comorbidities and Adverse Drug Reactions in HIV.
Taking Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) has little effect on kidney function, according to a new study.
We tell our patients that HIV has become like other chronic diseases -- and, largely, we believe it. These patients are aging along with us, and clinic visits have become more like routine checkups with continued praise for undetectable viral loads a...